Cargando…

Methylation status of the stimulator of interferon genes promoter in patients with chronic hepatitis B

The stimulator of interferon genes (STING) plays a crucial role in the recognition of a viral infection and subsequent stimulation of an immune response. However, it is unclear whether methylation of the STING promoter affects STING transcription and response to antiviral therapy. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chen-Si, Zhao, Qian, Zhang, Jun, Wang, Jing-Wen, Qian, Yu, Fan, Yu-Chen, Wang, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314766/ https://www.ncbi.nlm.nih.gov/pubmed/30593207 http://dx.doi.org/10.1097/MD.0000000000013904

Ejemplares similares

Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Jing-Wen, et al.
Publicado: (2020)

Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure
por: Zhao, Ze-Hua, et al.
Publicado: (2015)

Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure
por: Zhao, Qian, et al.
Publicado: (2019)

Hypomethylation of thymosin β4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure
por: Wang, He, et al.
Publicado: (2022)

Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Qian, Yu, et al.
Publicado: (2020)

SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure
por: Li, Feng, et al.
Publicado: (2023)

Interferon-Stimulated Gene 15 Conjugation Stimulates Hepatitis B Virus Production Independent of Type I Interferon Signaling Pathway In Vitro
por: Li, Yujia, et al.
Publicado: (2016)

F-box protein 43 promoter methylation as a novel biomarker for hepatitis B virus-associated hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2023)

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa
por: Wang, Shaoyang, et al.
Publicado: (2011)

Evolution of Interferon-Based Therapy for Chronic Hepatitis C
por: Chen, Chun-Hao, et al.
Publicado: (2010)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020)

Combined effect of pegylated interferon α with adefovir on renal function in Chinese patients with chronic hepatitis B
por: Su, Qian, et al.
Publicado: (2018)

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy
por: Bi, Xiaoyue, et al.
Publicado: (2023)

Interferon-stimulated gene 15 in hepatitis B-related liver diseases
por: Hoan, Nghiem Xuan, et al.
Publicado: (2016)

RHDV 3C protein antagonizes type I interferon signaling by cleaving interferon promoter stimulated 1 protein
por: Men, Yanjuan, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection
por: Mei, Shuqin, et al.
Publicado: (2022)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report
por: Liu, Yu, et al.
Publicado: (2022)

The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element
por: Guo, Yanan, et al.
Publicado: (2019)

Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients
por: Yu, Xiao-qi, et al.
Publicado: (2020)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
por: Huang, Yi-Wen, et al.
Publicado: (2022)

Interferon Alpha on Expression of hTERT mRNA in Peripheral Blood Mononuclear Cells of Patients with Chronic Hepatitis B
por: Zhu, Chuan-wu, et al.
Publicado: (2011)

Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells
por: Zhang, Jiaxuan, et al.
Publicado: (2022)

Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection
por: Tian, Cui-Huan, et al.
Publicado: (2019)

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
por: Huang, Yi-Wen, et al.
Publicado: (2020)

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
por: Li, Ning, et al.
Publicado: (2022)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
por: Li, Ming-Hui, et al.
Publicado: (2017)

Hepatitis B virus spliced variants are associated with an impaired response to interferon therapy
por: Chen, Jieliang, et al.
Publicado: (2015)

Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs
por: Li, Tao, et al.
Publicado: (2018)

Interferon and Hepatitis B: Current and Future Perspectives
por: Ye, Jianyu, et al.
Publicado: (2021)

Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA
por: Gao, Wen-Kang, et al.
Publicado: (2022)

IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection
por: Xie, Dong-Ying, et al.
Publicado: (2016)

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
por: Fan, He Bin, et al.
Publicado: (2012)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Decreased expression of interferon‐stimulated genes in B cells of patients with chronic hepatitis C during interferon‐free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort study
por: Arai, Jun, et al.
Publicado: (2020)

A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients
por: Lu, Jia-Jie, et al.
Publicado: (2012)

Methylation status of DDIT3 gene in Chronic Myeloid Leukemia
por: Wang, Ya-li, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r3fnt6bjandp00j9r865s97ndd